Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
about
Combatting substandard and falsified medicines: a view from RwandaSubstandard/counterfeit antimicrobial drugsInterventions to combat or prevent drug counterfeiting: a systematic reviewA current update on the rule of alternative and complementary medicine in the treatment of liver diseasesQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain21st century natural product research and drug development and traditional medicinesThe Global Drug Facility as an intervention in the market for tuberculosis drugsMonitoring the quality of medicines: results from Africa, Asia, and South AmericaSubstandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011).Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes.Global Antimicrobial Stewardship: A Closer Look at the Formidable Implementation Challenges.Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility.Illicit Distribution of Prescription Drugs: Report of Inadvertent Chloroquine Toxicity and a Market Survey of Businesses Serving Ethnic Minority Populations.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.Common errors in multidrug-resistant tuberculosis management.The Quality of Medicines Used in Children and Supplied by Private Pharmaceutical Wholesalers in Kinshasa, Democratic Republic of Congo: A Prospective Survey.Field detection devices for screening the quality of medicines: a systematic review
P2860
Q21034188-DCFA468C-626F-4CAD-9604-89AB56489B89Q27009319-09D9F7FC-4540-42B1-BB27-BD64B75E3616Q27010468-F4DC4ED8-5E1F-4FDE-8A83-C9852FFC6205Q27012998-56D9D2E3-88EF-4D6D-89C4-1EF140446C5FQ28538830-C7D7B797-F91F-423D-9844-8FC48CC375F1Q34602021-C9D9B51E-EA8E-47F1-8DD4-AD2B4ACC7836Q35606106-AA457CF3-41A5-45F7-B935-C7BAC6639E59Q35681768-03AD0D1D-1608-4067-BD93-28874721C9D7Q37065247-597272C9-9C4A-43D7-BD2F-625DCA1B9EF5Q37162418-9DA96467-019D-4CBF-94E0-B0119F021CB8Q37416040-BEEEB396-151B-477F-8768-33EA793C0D2DQ38264191-423FD74F-5BB9-480C-BA4F-C915411CDFA6Q38867438-DE9BC7EF-1E3C-4B2D-820B-FA7E068A2675Q40040578-863EB869-3192-4EBF-9E75-BCE82B56D1B0Q40656632-9BEE24E2-5F8A-4C56-8F27-C944DAB6FCB5Q41921386-1B4B0165-1DD1-4620-9A4D-2D8AA0A623F7Q42715629-08192EEA-F699-407B-A6EA-BE61EAF36937Q43971776-3AD61768-130B-439C-8B32-E7D4D5D8F611Q46241770-6A7C0E87-E138-4799-BB0B-FA1851C1211BQ48521945-EF47D642-C0EE-4973-A03B-81DA480091BEQ58693483-B7EDCDF8-66A8-4C05-927F-B8C94337A845
P2860
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
@en
type
label
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
@en
prefLabel
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
@en
P2093
P356
P1476
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
@en
P2093
P304
P356
10.5588/IJTLD.12.0355
P577
2013-01-14T00:00:00Z